E. Rene Rodriguez, MD

Appointed
2004

Education & Fellowships

Residency - The George Washington University School of Medicine and Health Sciences
Anatomic & Clinical Pathology
Washington, DC USA
1990

Fellowship - National Heart, Lung and Blood Institute
Cardiovascular Pathology
Bethesda, MD USA
1986

Medical Education - Universidad Autonoma Metropolitan Xochimilco
M.D.
Mexico D.F., Mexico
1982

Undergraduate - Universidad Nacional Autonoma De Mexico
B.S.
Mexico, Mexico
1976

Professional Highlights

• For additional conferences in which Dr. Rodriguez served as organizer or Chair, see Biographical Sketch.
• Chair, Cardiovascular Pathology Session, Ninth Banff Conference in Transplant Pathology, La Corua, Spain, June 2007
• Chair, Cardiovascular Pathology Session, Eight Banff Conference in Transplant Pathology, Edmonton, Alberta, Canada, July 2005
• Task Force on the Pathology of Heart Transplantation; Humoral Rejection Workgroup,
• International Society of Heart and Lung Transplantation; Consensus Meeting on Cardiac Rejection Grading, San Francisco, Calif., April 20-22, 2004
• Chair, Cardiovascular Pathology, Proffered Papers; United States and Canadian Academy of Pathology, University of Maryland, 2006
• "Overview of Genomics in Heart Failure"; Symposium 656, Genomics of Heart Failure: Ready for Prime Time? Atlanta, Ga., February 2006

Certifications

• Pathology - Anatomic & Clinical Pathology

Specialty Interests

Autopsy Pathology, cardiovascular pathology, cardiac transplant pathology, aortic diseases, valvular diseases, molecular diagnostics of cardiovascular diseases

Awards & Honors

• E. Rene Rodriguez, PI Core B, Active, PO1-HL-56091, NHLBI: Mechanisms of accelerated graft arteriosclerosis (PI of Core B Direct Costs, $922,009), 2003-2088
• E. Rene Rodriguez, Inactive, P01HL70295-01, NHLBI: Delayed type hypersensitivity and IFN-? in human graft arteriosclerosis($634,987.00), 2001-2006
• PI of Core D. Tissue repository and proteomics core

Memberships

• American Heart Association
• Association for Investigative Pathology
• International Society for Heart and Lung Transplantation
• United States and Canadian Academy of Pathology

See publications for E. Rene Rodriguez, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/28/2023, Dr. Rodriguez has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.